S. Ireland

发表

GR138676, a novel peptidic tachykinin antagonist which is potent at NK3 receptors

S. Arkinstall, R. Hagan, I. Beresford, 1994, Neuropeptides.

Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: New tools for investigating neurokinin function

R. Hagan, I. Beresford, S. Ireland, 1991, Neuropeptides.

Receptors mediating tachykinin‐induced contractile responses in guinea‐pig trachea

F. Bailey, R. Hagan, S. Ireland, 1991, British journal of pharmacology.

Potent and highly selective neurokinin antagonists.

J R Brown, J. R. Brown, R. Hagan, 1990, Journal of medicinal chemistry.

Pharmacological characterization of 5‐hydroxytryptamine‐induced depolarization of the rat isolated vagus nerve

M. B. Tyers, S. Ireland, M. Tyers, 1987, British journal of pharmacology.

The pharmacological characterization of 5‐HT3 receptors in three isolated preparations derived from guinea‐pig tissues

Gavin Kilpatrick, K. Bunce, A. Butler, 1990, British journal of pharmacology.

Investigation into species variants in tachykinin NK1 receptors by use of the non‐peptide antagonist, CP‐96,345

R. Hagan, I. Beresford, S. Ireland, 1991, British journal of pharmacology.

Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors.

L. P. Davies, S. Ireland, S J Ireland, 1992, Biochemical pharmacology.

Imidazo[1,2-b]Pyridazines. V. Syntheses and Central Nervous Activities of Some 3-Alkoxy-6-benzylthio(substituted benzylthio and Other phenylalkylthio)-2-phenyl(and substituted phenyl)imidazo[1,2-b]pyridazines

L. P. Davies, S. Ireland, G. Barlin, 1989 .

Imidazo[1,2-b]Pyridazines. VI. Syntheses and Central Nervous System Activities of Some 6-(Alkoxy- and Methylthio-phenoxy and Methoxybenzylthio)-3-methoxy-2-phenyl(substituted phenyl and pyridinyl)Imidazo[1,2-b]pyridazines

L. P. Davies, S. Ireland, G. Barlin, 1989 .

Imidazo[1,2-B]pyridazines. IX. Syntheses and Central Nervous System Activities of Some 3-Alkoxy-6-(o-alkoxy, o-methylthio- or o-fluoro-phenoxy)-2-arylimidazo[1,2-b]pyridazines

L. P. Davies, S. Ireland, G. Barlin, 1990 .

Imidazo[1,2-b]pyridazines. X. Syntheses and Central Nervous System Activities of Some 3-(Acetamido, benzamido, substituted benzamido or dimethylamino)methyl-2-(phenyl or substituted phenyl)-6-(halogeno, alkylthio, alkoxy, phenylthio, phenoxy, benzylthio or benzyloxy)imidazo[1,2-b]pyridazines

J. Zhang, L. P. Davies, S. Ireland, 1992 .

Syntheses, pharmacological evaluation and molecular modelling of substituted 6-alkoxyimidazo[1,2-b]pyridazines as new ligands for the benzodiazepine receptor

S. J. Ireland, P. Mátyus, L. P. Davies, 1996 .

Syntheses, Pharmacological Evaluation and Molecular Modelling of Substituted 6-Alkoxyimidazo(1,2-b)pyridazines as New Ligands for the Benzodiazepine Receptor.

P. Mátyus, L. P. Davies, M. Wong, 1996 .

Imidazo[1,2-b]pyridazines. XII. Syntheses and Central Nervous System Activities of Some Substituted Imidazo[1,2-b]pyridazines and Related Imidazo[1,2-a]pyridines, Imidazo[1,2-a]pyrimidines and Imidazo[1,2-a]pyrazines

J. Zhang, L. P. Davies, S. Ireland, 1992 .

Influence of peptidase inhibitors on responses to neurokinin receptor agonists in the guinea-pig trachea

S. Ireland, C. Jordan, M. Stephens-Smith, 1988, Regulatory Peptides.

Receptors mediating the contractile response to neurokinin agonists in the guinea-pig trachea

S. Ireland, P. Ward, C. Jordan, 1988, Regulatory Peptides.

Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists.

A. Mcelroy, R. Hagan, S. Ireland, 1992, Journal of medicinal chemistry.

Ondansetron and related 5-HT3 antagonists: recent advances.

Gavin Kilpatrick, A. Oxford, S. Ireland, 1992, Progress in medicinal chemistry.

Potential Antimalarials. XX. Mannich Base Derivatives of 2-[7-Chloroquinolin-4-ylamino and 7-Bromo(and 7-trifluoromethyl)-1,5-naphthyridin-4-ylamino]-4-chloro(or 4- or 6-t-Butyl or 4- or 5-fluoro)phenols and 4(or 6)-t-Butyl-2-(7-trifluoromethylquinolin-4-ylamino)phenol

K. Rieckmann, S. Ireland, B. Kotecka, 1994 .

Low molecular weight neurokinin NK2 antagonists

A. Mcelroy, J. Pritchard, R. Hagan, 1993 .

Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor.

A. Mcelroy, R. Hagan, S. Ireland, 1992, Journal of medicinal chemistry.

Characterization of tachykinin-induced ventral root depolarization in the neonatal rat isolated spinal cord

I. K. Wright, S. Ireland, C. Jordan, 1992, Neuroscience.

Ontogeny and characterization of [125I]Bolton Hunter-Eledoisin binding sites in rat spinal cord by quantitative autoradiography

R. Hagan, I. Beresford, J. Stables, 1992, Neuroscience.

Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

A Butler, J. Hill, A. Butler, 1988, British journal of pharmacology.

Pharmacological characterization of 5‐hydroxytryptamine‐induced hyperpolarization of the rat superior cervical ganglion

S. Ireland, C. Jordan, 1987, British journal of pharmacology.

Influence of 5‐hydroxytryptamine uptake on the apparent 5‐hydroxytryptamine antagonist potency of metoclopramide in the rat isolated superior cervical ganglion

D. Straughan, S. Ireland, M. Tyers, 1987, British journal of pharmacology.

Origin of 5‐hydroxytryptamine‐induced hyperpolarization of the rat superior cervical ganglion and vagus nerve

S. Ireland, 1987, British journal of pharmacology.

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.

Julia M. Hill, R. Hagan, A. Butler, 1987, European journal of pharmacology.

Characterisation of tachykinin receptors in the rat isolated oesophagus

R. Hagan, J. Stables, S. Ireland, 1991, Regulatory Peptides.

Potential Antimalarials. XXI. Mannich Base Derivatives of 4-[7-Chloro(and 7-trifluoromethyl)quinolin-4-ylamino]phenols

K. Rieckmann, S. Ireland, B. Kotecka, 1994 .